Hydromorphone

Pain Management

Hydromorphone is primarily used to treat moderate to severe pain. It is an opioid analgesic that works by altering the way the brain and nervous system perceive and respond to pain.

Types of Use

• Acute Pain: Immediate-release formulations, including tablets, oral liquids, and injections, are used for the management of sudden or short-term severe pain.
• Chronic Pain: Extended-release tablets or capsules are used for patients who require continuous, around-the-clock pain relief for an extended period. These long-acting forms are generally reserved for patients who are already opioid-tolerant, meaning they have been taking regular doses of an opioid medication for a specific amount of time.

Healthcare providers typically prescribe hydromorphone only when non-opioid medications or immediate-release opioids do not provide sufficient pain relief or are not appropriate for the patient's condition.

Mechanism of Action

Hydromorphone belongs to a class of medications called opioid analgesics. It is primarily used to manage severe pain when other treatments are not effective or cannot be tolerated.

The medication works through the following processes:

• Binding to Receptors: Hydromorphone travels through the bloodstream to the central nervous system. It attaches to specific sites called opioid receptors located in the brain and spinal cord.
• Blocking Pain Signals: Once attached, the drug interferes with the transmission of pain signals between the body and the brain.
• Altering Perception: It changes the way the brain perceives and responds to pain, making the sensation less intense.

Because it acts directly on the central nervous system, hydromorphone can also affect other bodily functions, such as breathing and digestion, and may influence the brain's reward system.

Common Side Effects

Many people using hydromorphone experience mild side effects. These may include:

• Drowsiness, dizziness, or lightheadedness
• Nausea, vomiting, or stomach pain
• Constipation
• Headache
• Dry mouth
• Sweating, flushing, or itching
• Feelings of extreme happiness or sadness
• Tiredness or weakness

Serious Side Effects

Some side effects can be severe. Seek emergency medical help immediately if you experience:

• Slowed, shallow, or difficult breathing
• Extreme sleepiness or inability to wake up
• Chest pain or irregular heartbeat
• Seizures
• Confusion, hallucinations, or agitation
• Fever, shivering, or severe muscle stiffness
• Swelling of the face, throat, tongue, or lips
• Hives or skin rash
• Fainting
• Difficulty swallowing or hoarseness

Long-term use of hydromorphone may lead to adrenal insufficiency, which can cause symptoms like persistent nausea, vomiting, loss of appetite, or unusual tiredness. Opioid medications may also affect fertility in men and women; however, it is not known if these effects are permanent.

Boxed Warnings

Hydromorphone carries several boxed warnings due to the potential for severe harm or death:

• Addiction, Abuse, and Misuse: Use of this medication exposes individuals to the risk of opioid addiction and misuse, which can lead to overdose and death.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal breathing problems may occur. This risk is highest when starting the medication or following a dose increase.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by a child, can result in a fatal overdose.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use of hydromorphone during pregnancy can cause life-threatening withdrawal symptoms in the newborn baby.
• Risks from Use with Benzodiazepines or Alcohol: Combining hydromorphone with benzodiazepines, other central nervous system depressants, or alcohol may result in profound sedation, respiratory depression, coma, and death.

Contraindications

Hydromorphone is not recommended for individuals with certain health conditions, including:

• Significant respiratory depression or severe lung conditions, such as acute or severe bronchial asthma in an unmonitored setting.
• Known or suspected gastrointestinal obstruction, including a condition called paralytic ileus where the bowels do not move correctly.
• Hypersensitivity to hydromorphone, hydromorphone salts, or other ingredients in the formulation, such as sulfites found in certain injections.

Other Major Precautions

Adrenal Insufficiency: Long-term use of opioids may lead to adrenal insufficiency, a condition where the adrenal glands do not produce enough of certain hormones. Symptoms can include nausea, vomiting, dizziness, and severe fatigue.

Severe Hypotension: Hydromorphone may cause a serious drop in blood pressure (hypotension), which can lead to fainting or dizziness, particularly when moving from a sitting or lying position to standing.

Seizures: This medication may increase the risk of seizures in individuals with known seizure disorders or in certain other medical conditions.

Gastrointestinal Effects: Hydromorphone may cause severe constipation and can obscure the diagnosis or clinical course in patients with acute abdominal conditions.

Withdrawal: Stopping the medication suddenly in individuals who have become physically dependent can lead to severe withdrawal symptoms. Healthcare providers typically manage this by gradually reducing the dose.

Pregnancy

Using hydromorphone for an extended period during pregnancy can cause neonatal opioid withdrawal syndrome (NOWS). This is a potentially life-threatening condition where the newborn experiences withdrawal symptoms after birth because of exposure to the medication in the womb.

Symptoms of withdrawal in a newborn may include:

• High-pitched crying and irritability
• Tremors or shaking
• Vomiting or diarrhea
• Failure to gain weight

If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the risks. This medication should only be used during pregnancy when the benefits clearly outweigh the risks to the developing baby.

Breastfeeding

Hydromorphone is known to pass into breast milk. This can cause the nursing infant to experience dangerous side effects, including excessive sleepiness, limpness, or difficulty breathing.

Healthcare providers typically recommend monitoring breastfed infants closely for these signs. If an infant shows unusual snoring, extreme sleepiness, or difficulty breathing, seek emergency medical care immediately. Discuss with your doctor whether to continue breastfeeding while taking this medication.

Oral Formulations

Hydromorphone is available in several oral forms to manage different types of pain:

• Immediate-release tablets: These are typically used for the management of acute pain.
• Extended-release tablets: These are intended for patients who require continuous, around-the-clock opioid treatment for an extended period.
• Oral liquid: A solution is available for those who prefer or require a liquid format.

Injectable Formulations

Injectable hydromorphone is used in clinical settings and can be administered through several methods:

• Intravenous (IV) injection or infusion.
• Intramuscular (IM) injection.
• Subcutaneous (under the skin) injection.

There are standard concentrations as well as high-potency formulations intended for use in specific clinical situations.

Other Formulations

Hydromorphone is also produced as a rectal suppository for use when oral or injectable routes are not preferred or possible.

FDA Approval and Indications

Hydromorphone is approved by the U.S. Food and Drug Administration (FDA) for the management of pain severe enough to require an opioid analgesic and for which alternative treatments, such as non-opioid medications or immediate-release opioids, are inadequate or not tolerated. It is available in various forms, including immediate-release tablets, oral solutions, and extended-release capsules.

Controlled Substance Status

The Drug Enforcement Administration (DEA) classifies hydromorphone as a Schedule II controlled substance. This classification indicates that while the drug has a currently accepted medical use, it also has a high potential for abuse, which may lead to severe psychological or physical dependence.

Boxed Warnings

The FDA requires a Boxed Warning—its most serious warning—for hydromorphone products. These warnings highlight several critical risks:

• Addiction, Abuse, and Misuse: Use of hydromorphone exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur, particularly when starting the medication or following a dose increase.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use of hydromorphone during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated.
• Risks from Concomitant Use with Benzodiazepines: Using opioids with benzodiazepines or other central nervous system (CNS) depressants may result in profound sedation, respiratory depression, coma, and death.

Risk Evaluation and Mitigation Strategy (REMS)

To ensure the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the FDA has required a Risk Evaluation and Mitigation Strategy (REMS) for these products. Under the Opioid Analgesic REMS, drug companies must make REMS-compliant education programs available to healthcare providers.

Risk of Addiction and Misuse

Hydromorphone is an opioid pain medication that has a high potential for addiction, even when taken at recommended doses. Because of this risk, it is classified as a Schedule II controlled substance. Addiction involves a powerful craving for the drug and continued use despite knowing it causes harm.

The risk of addiction is higher for individuals who:

• Have a personal or family history of substance use disorders, including alcohol or drug abuse.
• Have a history of mental health conditions, such as depression or anxiety.
• Take the medication in higher doses or for longer periods than prescribed.

Preventing Abuse

To minimize the risk of addiction, healthcare providers prescribe the lowest effective dose for the shortest duration necessary. It is critical to follow all dosing instructions exactly. Misusing hydromorphone by crushing, chewing, or dissolving tablets for injection can lead to a fatal overdose.

Sharing hydromorphone with others is illegal and can be life-threatening for the person receiving it. Patients should store the medication in a secure place, ideally locked, to prevent theft or accidental ingestion by children or others in the household.

Signs of a Problem

Patients and caregivers should be alert for signs of misuse or addiction, such as:

• Taking the medication more often than prescribed.
• Seeking prescriptions from multiple doctors.
• Changes in mood or social behavior.
• Strong cravings for the drug.

If you suspect you or someone else is developing an addiction to hydromorphone, contact a healthcare professional immediately for guidance on treatment and support.